Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide
about
Neoantigen-based cancer immunotherapyTumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentationThe class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosolThe gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 miceA mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma.Rapid accumulation of adoptively transferred CD8+ T cells at the tumor site is associated with long-term control of SV40 T antigen-induced tumors.The immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein.Isolation of unknown genes from human bone marrow by differential screening and single-pass cDNA sequence determinationTransloading of tumor antigen-derived peptides into antigen-presenting cellsRibosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading framesVertebrate mRNAs with a 5'-terminal pyrimidine tract are candidates for translational repression in quiescent cells: characterization of the translational cis-regulatory element.Promises and limitations of murine models in the development of anticancer T-cell vaccines.T cell molecular targets for psoralens.Tum- antigens, TSTA, and T cell immune surveillance.In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes.Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes.Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations.Ribosomal versus non-ribosomal cellular antigens: factors determining efficiency of indirect presentation to CD4+ T cells.Genes coding for tumor antigens recognized by cytolytic T lymphocytes.Novel proteins associated with MHC class I antigens in cells expressing the adenovirus protein E3/19K.Definition and transfer of a serological epitope specific for peptide-empty forms of MHC class I.A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-ECancer antigens: immune recognition of self and altered self.H-2Kd-restricted antigenic peptides share a simple binding motif.Characterization of the individual and cross-reactive antigens involved in the anti-tumor immunity induced by use of an H-2K-erbB recombinant gene transfectant.Structural definition of the H-2Kd peptide-binding motif.
P2860
Q26738693-72C3FFB2-A4C3-4AD2-8796-0C25E38410FCQ28646520-317A386A-3894-4E90-AE00-8420A8749FFCQ30442820-5C73DB1D-9A44-4BBE-9C4C-83E21B1A615DQ33387226-3A1CD325-D852-4F37-84CD-7F37E5FF660FQ34021153-54CDB4E6-EAC2-40FD-8B27-2D54FF98FBAFQ34216825-1DD84263-2E1F-40D2-9AF7-4FEA9A97A9D6Q35049933-17572495-1BF7-4471-A7BE-6F06A870395CQ35944449-787DAFB0-6CA3-46F3-A9C7-9D2961600AFDQ36084026-1BFCFD0A-9843-47DE-A2FF-C2F17D45B9BAQ36367448-68038404-C40C-4015-BF18-B098A3F2CA7AQ36654513-E1BC6B8B-4E5C-413A-985D-77164D8FA016Q36684482-6EFD82E4-CA8B-4289-B593-D7AB206CDD61Q36968762-D3963640-40AC-4B05-9375-387EFC73B812Q36968849-CC07058B-4100-4A1B-9F6D-EA7A45CC27D6Q37640068-3ADC1E27-E76E-431E-A902-DFC30853AC67Q37851050-78023963-C64B-4EE5-80B5-EE5F1ED5E019Q38730989-A49506E4-75CA-40B9-BF8F-EC6932B58DF8Q39136403-AA44E79B-0D18-4752-AF98-38CBAB705CD4Q39724285-A8E52F2C-2C9C-4F08-B066-A8F0976D4AD6Q40433302-0FE2DEF6-93F2-47B2-9168-DD65734117C9Q40873636-0D4B4D34-7F3F-4EEE-AA2A-5136A3BAA00BQ40913320-A0B7D65F-0CC2-46C9-8214-444B60245454Q42603854-AB064C83-D8FA-419E-9F21-62DE166837EEQ42650335-233C0AD3-8B97-42D1-84C6-2087DD7AB457Q42768137-76E344D7-59ED-4FBF-B88F-D0EBEDDCA529Q43988409-B8D4D6B9-7702-46FD-8830-3DD231F456EEQ46941039-C009090C-DD85-403D-9D5B-33AF39111CC0
P2860
Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide
description
1990 nî lūn-bûn
@nan
1990 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Structure of the gene of tum- ...... erates a new antigenic peptide
@ast
Structure of the gene of tum- ...... erates a new antigenic peptide
@en
Structure of the gene of tum- ...... rates a new antigenic peptide.
@nl
type
label
Structure of the gene of tum- ...... erates a new antigenic peptide
@ast
Structure of the gene of tum- ...... erates a new antigenic peptide
@en
Structure of the gene of tum- ...... rates a new antigenic peptide.
@nl
prefLabel
Structure of the gene of tum- ...... erates a new antigenic peptide
@ast
Structure of the gene of tum- ...... erates a new antigenic peptide
@en
Structure of the gene of tum- ...... rates a new antigenic peptide.
@nl
P2093
P2860
P356
P1476
Structure of the gene of tum- ...... erates a new antigenic peptide
@en
P2093
De Plaen E
Maryanski JL
Wildmann C
de Bergeyck V
P2860
P356
10.1084/JEM.172.1.35
P407
P577
1990-07-01T00:00:00Z